Data / Form D filings / Promedix, Inc.
Promedix, Inc.: Form D filings
Promedix, Inc., a biotechnology company in Portland, OR, filed 6 Form D notices with the SEC between 2021 and 2024. The latest, on December 17, 2024, reports $200,000 sold of a $200,000 offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4640 SW MACADAM AVENUE, SUITE 200, Portland, OR, 97239
- Phone
- (503) 961-5787
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Oregon
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1858277
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 17, 2024 | New notice | $200,000 | $200,000 | 1 | Dec 2, 2024 | sec.gov | |
| Sep 11, 2023 | Amendment | $310,000 | $310,000 | 4 | Oct 17, 2022 | sec.gov | |
| Sep 11, 2023 | Amendment | $162,778 | $162,778 | 3 | Oct 31, 2022 | sec.gov | |
| Oct 31, 2022 | New notice | $50,000 | $50,000 | 1 | Oct 17, 2022 | sec.gov | |
| Oct 31, 2022 | New notice | $50,000 | $50,000 | 1 | Oct 31, 2022 | sec.gov | |
| Apr 23, 2021 | New notice | $250,000 | $250,000 | 1 | Apr 9, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Matthew Hansen | Executive Officer, Director | |
| Steven Baker | Executive Officer | |
| Scott Filer | Executive Officer, Director | |
| David Sheridan | Executive Officer, Director | |
| Robert Jenks | Executive Officer |
Other biotechnology companies in Oregon that filed recently
- UBIVAC, INC. $80,000 · Aug 27, 2026
- Trace Biosciences Inc. $8.3 million · Aug 12, 2026
Every Form D from the week of Dec 16, 2024 · All recent filings in Oregon · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Promedix, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.